Nuzenio

Companion Diagnostic

Companion Diagnostic news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 15 publisher sources 100/100 entity strength

Latest news

AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access - Yahoo Finance UKYahoo Finance UK · Sat, 08 Aug 2026 15:12:37 GMTOGT begins full IVDR transition for CytoCell FISH probe portfolio - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 15:00:43 GMT‘Benchmark’ companion animal TB diagnostic test now available - Vet TimesVet Times · Fri, 07 Aug 2026 12:59:21 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMTSophia Genetics expands AstraZeneca partnership with two cDX programs - AllSciAllSci · Thu, 06 Aug 2026 13:57:38 GMTEU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - OncLiveOncLive · Thu, 06 Aug 2026 13:13:30 GMTNatera seeks Japan’s PMDA approval for Signatera test in MIBC - Medical Device NetworkMedical Device Network · Thu, 06 Aug 2026 10:17:11 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMT

Timeline

Sat, 08 Aug 2026 15:12:37 GMTAstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access - Yahoo Finance UK
Fri, 07 Aug 2026 15:00:43 GMTOGT begins full IVDR transition for CytoCell FISH probe portfolio - Manufacturing Chemist
Fri, 07 Aug 2026 12:59:21 GMT‘Benchmark’ companion animal TB diagnostic test now available - Vet Times
Fri, 07 Aug 2026 11:00:39 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing Chemist
Thu, 06 Aug 2026 13:57:38 GMTSophia Genetics expands AstraZeneca partnership with two cDX programs - AllSci
Thu, 06 Aug 2026 13:13:30 GMTEU Clears PD-L1 IHC 22C3 pharmDx as Companion Diagnostic for Pembrolizumab in Ovarian Cancer - OncLive

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Companion Diagnostic.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.